The role of inflammation and infection in preterm birth

Clinics in Perinatology

Volumn 38, Issue 3, 2011, Pages 385-406

  Bastek, Jamie A ^a,b,c   Gómez, Luis M ^a,b,c   Elovitz, Michal A ^a,b  

^a Maternal and Child Health Research Program   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Department of Maternal Fetal Medicine ^*  (United States)

Author keywords

Animal model; Biomarkers; Infection; Inflammation; Preterm birth

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CLINDAMYCIN; DEXAMETHASONE; GLUCOCORTICOID; HYDROXYPROGESTERONE CAPROATE; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MEDROXYPROGESTERONE ACETATE; METRONIDAZOLE; MIFEPRISTONE;

BACTERIAL COLONIZATION; DISEASE ASSOCIATION; HUMAN; IMMUNE RESPONSE; INCIDENCE; INFECTION; INFLAMMATION; INTRAUTERINE INFECTION; MORBIDITY; NONHUMAN; PATHOGENESIS; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW; VAGINITIS;

FEMALE; HUMANS; INCIDENCE; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFLAMMATION; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREMATURE BIRTH; UNITED STATES;

EID: 80052296914     PISSN: 00955108     EISSN: 15579840     Source Type: Journal    
DOI: 10.1016/j.clp.2011.06.003     Document Type: Review

References (186)

1. Hamilton B.E., Minino A.M., Martin J.A., et al. Annual summary of vital statistics: 2005. Pediatrics 2007, 119(2):345-360.
2. Goldenberg R.L., Culhane J.F., Iams J.D., et al. Epidemiology and causes of preterm birth. Lancet 2008, 371(9606):75-84.
3. Elovitz M.A. Anti-inflammatory interventions in pregnancy: now and the future. Semin Fetal Neonatal Med 2006, 11(5):327-332.
4. Elovitz M.A., Mrinalini C. Animal models of preterm birth. Trends Endocrinol Metab 2004, 15(10):479-487.
5. Romero R., Brody D.T., Oyarzun E., et al. Infection and labor. III. Interleukin-1: a signal for the onset of parturition. Am J Obstet Gynecol 1989, 160(5 Pt 1):1117-1123.
6. Cherouny P.H., Pankuch G.A., Romero R., et al. Neutrophil attractant/activating peptide-1/interleukin-8: association with histologic chorioamnionitis, preterm delivery, and bioactive amniotic fluid leukoattractants. Am J Obstet Gynecol 1993, 169(5):1299-1303.
7. Romero R., Manogue K.R., Mitchell M.D., et al. Infection and labor. IV. Cachectin-tumor necrosis factor in the amniotic fluid of women with intraamniotic infection and preterm labor. Am J Obstet Gynecol 1989, 161(2):336-341.
8. Goldenberg R.L., Hauth J.C., Andrews W.W. Intrauterine infection and preterm delivery. N Engl J Med 2000, 342(20):1500-1507.
9. Knox I.C., Hoerner J.K. The role of infection in premature rupture of the membranes. Am J Obstet Gynecol 1950, 59(1):190-194.
10. Gilles H.M., Lawson J.B., Sibelas M., et al. Malaria, anaemia and pregnancy. Ann Trop Med Parasitol 1969, 63(2):245-263.
11. Heard N., Jordan T. An investigation of malaria during pregnancy in Zimbabwe. Cent Afr J Med 1981, 27(4):62-63. 66-8.
12. Patrick M.J. Influence of maternal renal infection on the foetus and infant. Arch Dis Child 1967, 42(222):208-213.
13. Wren B.G. Subclinical renal infection and prematurity. Med J Aust 1969, 2(12):596-600.
14. Goldenberg R.L., Culhane J.F., Johnson D.C. Maternal infection and adverse fetal and neonatal outcomes. Clin Perinatol 2005, 32(3):523-559.
15. Romero R., Oyarzun E., Mazor M., et al. Meta-analysis of the relationship between asymptomatic bacteriuria and preterm delivery/low birth weight. Obstet Gynecol 1989, 73(4):576-582.
16. Goepfert A.R., Jeffcoat M.K., Andrews W.W., et al. Periodontal disease and upper genital tract inflammation in early spontaneous preterm birth. Obstet Gynecol 2004, 104(4):777-783.
17. Srinivas S.K., Sammel M.D., Stamilio D.M., et al. Periodontal disease and adverse pregnancy outcomes: is there an association?. Am J Obstet Gynecol 2009, 200(5):497. e1-8.
18. Offenbacher S., Beck J.D., Jared H.L., et al. Effects of periodontal therapy on rate of preterm delivery: a randomized controlled trial. Obstet Gynecol 2009, 114(3):551-559.
19. Newnham J.P., Newnham I.A., Ball C.M., et al. Treatment of periodontal disease during pregnancy: a randomized controlled trial. Obstet Gynecol 2009, 114(6):1239-1248.
20. Macones G.A., Parry S., Nelson D.B., et al. Treatment of localized periodontal disease in pregnancy does not reduce the occurrence of preterm birth: results from the Periodontal Infections and Prematurity Study (PIPS). Am J Obstet Gynecol 2010, 202(2):147. e1-8.
21. Goncalves L.F., Chaiworapongsa T., Romero R. Intrauterine infection and prematurity. Ment Retard Dev Disabil Res Rev 2002, 8(1):3-13.
22. Romero R., Salafia C.M., Athanassiadis A.P., et al. The relationship between acute inflammatory lesions of the preterm placenta and amniotic fluid microbiology. Am J Obstet Gynecol 1992, 166(5):1382-1388.
23. Russell P. Inflammatory lesions of the human placenta. III. The histopathology of villitis of unknown aetiology. Placenta 1980, 1(3):227-244.
24. Mueller-Heubach E., Rubinstein D.N., Schwarz S.S. Histologic chorioamnionitis and preterm delivery in different patient populations. Obstet Gynecol 1990, 75(4):622-626.
25. Yoon B.H., Romero R., Park J.S., et al. The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol 2000, 183(5):1124-1129.
26. Romero R., Mazor M. Infection and preterm labor. Clin Obstet Gynecol 1988, 31(3):553-584.
27. Blumenfeld Y.J., Lee H.C., Gould J.B., et al. The effect of preterm premature rupture of membranes on neonatal mortality rates. Obstet Gynecol 2010, 116(6):1381-1386.
28. Hargreaves D.C., Medzhitov R. Innate sensors of microbial infection. J Clin Immunol 2005, 25(6):503-510.
29. Youssef R.E., Ledingham M.A., Bollapragada S.S., et al. The role of toll-like receptors (TLR-2 and -4) and triggering receptor expressed on myeloid cells 1 (TREM-1) in human term and preterm labor. Reprod Sci 2009, 16(9):843-856.
30. Kim Y.M., Romero R., Chaiworapongsa T., et al. Toll-like receptor-2 and -4 in the chorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with chorioamnionitis. Am J Obstet Gynecol 2004, 191(4):1346-1355.
31. Krikun G., Lockwood C.J., Abrahams V.M., et al. Expression of Toll-like receptors in the human decidua. Histol Histopathol 2007, 22(8):847-854.
32. Romero R., Wu Y.K., Brody D.T., et al. Human decidua: a source of interleukin-1. Obstet Gynecol 1989, 73(1):31-34.
33. Romero R., Durum S., Dinarello C.A., et al. Interleukin-1 stimulates prostaglandin biosynthesis by human amnion. Prostaglandins 1989, 37(1):13-22.
34. Sadowsky D.W., Novy M.J., Witkin S.S., et al. Dexamethasone or interleukin-10 blocks interleukin-1beta-induced uterine contractions in pregnant rhesus monkeys. Am J Obstet Gynecol 2003, 188(1):252-263.
35. Romero R., Mazor M., Tartakovsky B. Systemic administration of interleukin-1 induces preterm parturition in mice. Am J Obstet Gynecol 1991, 165(4 Pt 1):969-971.
36. Andrews W.W., Hauth J.C., Goldenberg R.L., et al. Amniotic fluid interleukin-6: correlation with upper genital tract microbial colonization and gestational age in women delivered after spontaneous labor versus indicated delivery. Am J Obstet Gynecol 1995, 173(2):606-612.
37. Cox S.M., King M.R., Casey M.L., et al. Interleukin-1 beta, -1 alpha, and -6 and prostaglandins in vaginal/cervical fluids of pregnant women before and during labor. J Clin Endocrinol Metab 1993, 77(3):805-815.
38. Gomez R., Romero R., Galasso M., et al. The value of amniotic fluid interleukin-6, white blood cell count, and gram stain in the diagnosis of microbial invasion of the amniotic cavity in patients at term. Am J Reprod Immunol 1994, 32(3):200-210.
39. Hillier S.L., Witkin S.S., Krohn M.A., et al. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstet Gynecol 1993, 81(6):941-948.
40. Messer J., Eyer D., Donato L., et al. Evaluation of interleukin-6 and soluble receptors of tumor necrosis factor for early diagnosis of neonatal infection. J Pediatr 1996, 129(4):574-580.
41. Romero R., Avila C., Santhanam U., et al. Amniotic fluid interleukin 6 in preterm labor. Association with infection. J Clin Invest 1990, 85(5):1392-1400.
42. Saito S., Kasahara T., Kato Y., et al. Elevation of amniotic fluid interleukin 6 (IL-6), IL-8 and granulocyte colony stimulating factor (G-CSF) in term and preterm parturition. Cytokine 1993, 5(1):81-88.
43. Ghezzi F., Gomez R., Romero R., et al. Elevated interleukin-8 concentrations in amniotic fluid of mothers whose neonates subsequently develop bronchopulmonary dysplasia. Eur J Obstet Gynecol Reprod Biol 1998, 78(1):5-10.
44. Romero R., Ceska M., Avila C., et al. Neutrophil attractant/activating peptide-1/interleukin-8 in term and preterm parturition. Am J Obstet Gynecol 1991, 165(4 Pt 1):813-820.
45. Yoon B.H., Romero R., Jun J.K., et al. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1997, 177(4):825-830.
46. Gonzalez C., Cava F., Ayllon A., et al. Biological variation of interleukin-1beta, interleukin-8 and tumor necrosis factor-alpha in serum of healthy individuals. Clin Chem Lab Med 2001, 39(9):836-841.
47. Romero R., Mazor M., Wu Y.K., et al. Infection in the pathogenesis of preterm labor. Semin Perinatol 1988, 12(4):262-279.
48. Casey M.L., Cox S.M., Beutler B., et al. Cachectin/tumor necrosis factor-alpha formation in human decidua. Potential role of cytokines in infection-induced preterm labor. J Clin Invest 1989, 83(2):430-436.
49. Romero R., Mazor M., Manogue K., et al. Human decidua: a source of cachectin-tumor necrosis factor. Eur J Obstet Gynecol Reprod Biol 1991, 41(2):123-127.
50. Fortunato S.J., Menon R., Lombardi S.J. Role of tumor necrosis factor-alpha in the premature rupture of membranes and preterm labor pathways. Am J Obstet Gynecol 2002, 187(5):1159-1162.
51. Watari K., Nakao S., Fotovati A., et al. Role of macrophages in inflammatory lymphangiogenesis: enhanced production of vascular endothelial growth factor C and D through NF-kappaB activation. Biochem Biophys Res Commun 2008, 377(3):826-831.
52. Maymon E., Romero R., Pacora P., et al. Evidence of in vivo differential bioavailability of the active forms of matrix metalloproteinases 9 and 2 in parturition, spontaneous rupture of membranes, and intra-amniotic infection. Am J Obstet Gynecol 2000, 183(4):887-894.
53. Romero R., Chaiworapongsa T., Espinoza J., et al. Fetal plasma MMP-9 concentrations are elevated in preterm premature rupture of the membranes. Am J Obstet Gynecol 2002, 187(5):1125-1130.
54. Chwalisz K., Benson M., Scholz P., et al. Cervical ripening with the cytokines interleukin 8, interleukin 1 beta and tumour necrosis factor alpha in guinea-pigs. Hum Reprod 1994, 9(11):2173-2181.
55. Kajikawa S., Kaga N., Futamura Y., et al. Lipoteichoic acid induces preterm delivery in mice. J Pharmacol Toxicol Methods 1998, 39(3):147-154.
56. Hirsch E., Filipovich Y., Mahendroo M. Signaling via the type I IL-1 and TNF receptors is necessary for bacterially induced preterm labor in a murine model. Am J Obstet Gynecol 2006, 194(5):1334-1340.
57. Klein L.L., Gibbs R.S. Infection and preterm birth. Obstet Gynecol Clin North Am 2005, 32(3):397-410.
58. Keelan J.A., Blumenstein M., Helliwell R.J., et al. Cytokines, prostaglandins and parturition-a review. Placenta 2003, 24(Suppl A):S33-S46.
59. Romero R., Espinoza J., Kusanovic J.P., et al. The preterm parturition syndrome. BJOG 2006, 113(Suppl 3):17-42.
60. Mays J.K., Figueroa R., Shah J., et al. Amniocentesis for selection before rescue cerclage. Obstet Gynecol 2000, 95(5):652-655.
61. Romero R., Gonzalez R., Sepulveda W., et al. Infection and labor. VIII. Microbial invasion of the amniotic cavity in patients with suspected cervical incompetence: prevalence and clinical significance. Am J Obstet Gynecol 1992, 167(4 Pt 1):1086-1091.
62. Guzick D.S., Winn K. The association of chorioamnionitis with preterm delivery. Obstet Gynecol 1985, 65(1):11-16.
63. Markenson G.R., Martin R.K., Tillotson-Criss M., et al. The use of the polymerase chain reaction to detect bacteria in amniotic fluid in pregnancies complicated by preterm labor. Am J Obstet Gynecol 1997, 177(6):1471-1477.
64. Harger J.H., Meyer M.P., Amortegui A., et al. Low incidence of positive amnionic fluid cultures in preterm labor at 27-32 weeks in the absence of clinical evidence of chorioamnionitis. Obstet Gynecol 1991, 77(2):228-234.
65. Perni S.C., Vardhana S., Korneeva I., et al. Mycoplasma hominis and Ureaplasma urealyticum in midtrimester amniotic fluid: association with amniotic fluid cytokine levels and pregnancy outcome. Am J Obstet Gynecol 2004, 191(4):1382-1386.
66. Oh K.J., Lee S.E., Jung H., et al. Detection of ureaplasmas by the polymerase chain reaction in the amniotic fluid of patients with cervical insufficiency. J Perinat Med 2010, 38(3):261-268.
67. Tsekoura E.A., Konstantinidou A., Papadopoulou S., et al. Adenovirus genome in the placenta: association with histological chorioamnionitis and preterm birth. J Med Virol 2010, 82(8):1379-1383.
68. Oyarzun E., Yamamoto M., Kato S., et al. Specific detection of 16 micro-organisms in amniotic fluid by polymerase chain reaction and its correlation with preterm delivery occurrence. Am J Obstet Gynecol 1998, 179(5):1115-1119.
69. Steel J.H., Malatos S., Kennea N., et al. Bacteria and inflammatory cells in fetal membranes do not always cause preterm labor. Pediatr Res 2005, 57(3):404-411.
70. McDonald H.M., Brocklehurst P., Gordon A. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2007, 1. CD000262.
71. Okun N., Gronau K.A., Hannah M.E. Antibiotics for bacterial vaginosis or Trichomonas vaginalis in pregnancy: a systematic review. Obstet Gynecol 2005, 105(4):857-868.
72. Goldenberg R.L., Culhane J.F. Infection as a cause of preterm birth. Clin Perinatol 2003, 30(4):677-700.
73. Romero R., Espinoza J., Goncalves L.F., et al. The role of inflammation and infection in preterm birth. Semin Reprod Med 2007, 25(1):21-39.
74. Galask R.P., Varner M.W., Petzold C.R., et al. Bacterial attachment to the chorioamniotic membranes. Am J Obstet Gynecol 1984, 148(7):915-928.
75. Cassell G.H., Davis R.O., Waites K.B., et al. Isolation of Mycoplasma hominis and Ureaplasma urealyticum from amniotic fluid at 16-20 weeks of gestation: potential effect on outcome of pregnancy. Sex Transm Dis 1983, 10(Suppl 4):294-302.
76. Horowitz S., Mazor M., Romero R., et al. Infection of the amniotic cavity with Ureaplasma urealyticum in the midtrimester of pregnancy. J Reprod Med 1995, 40(5):375-379.
77. Gray D.J., Robinson H.B., Malone J., et al. Adverse outcome in pregnancy following amniotic fluid isolation of Ureaplasma urealyticum. Prenat Diagn 1992, 12(2):111-117.
78. King J., Flenady V. Prophylactic antibiotics for inhibiting preterm labour with intact membranes. Cochrane Database Syst Rev 2002, 4. CD000246.
79. Debillon T., Gras-Leguen C., Verielle V., et al. Intrauterine infection induces programmed cell death in rabbit periventricular white matter. Pediatr Res 2000, 47(6):736-742.
80. Gibbs R.S., Davies J.K., McDuffie R.S., et al. Chronic intrauterine infection and inflammation in the preterm rabbit, despite antibiotic therapy. Am J Obstet Gynecol 2002, 186(2):234-239.
81. Goldenberg R.L., Mercer B.M., Meis P.J., et al. The preterm prediction study: fetal fibronectin testing and spontaneous preterm birth. NICHD Maternal Fetal Medicine Units Network. Obstet Gynecol 1996, 87(5 Pt 1):643-648.
82. Goldenberg R.L., Klebanoff M., Carey J.C., et al. Vaginal fetal fibronectin measurements from 8 to 22 weeks' gestation and subsequent spontaneous preterm birth. Am J Obstet Gynecol 2000, 183(2):469-475.
83. Goldenberg R.L., Thom E., Moawad A.H., et al. The preterm prediction study: fetal fibronectin, bacterial vaginosis, and peripartum infection. NICHD Maternal Fetal Medicine Units Network. Obstet Gynecol 1996, 87(5 Pt 1):656-660.
84. Andrews W.W., Sibai B.M., Thom E.A., et al. Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women. Obstet Gynecol 2003, 101(5 Pt 1):847-855.
85. Khoury M.J., Bertram L., Boffetta P., et al. Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases. Am J Epidemiol 2009, 170(3):269-279.
86. Winkvist A., Mogren I., Hogberg U. Familial patterns in birth characteristics: impact on individual and population risks. Int J Epidemiol 1998, 27(2):248-254.
87. Macones G.A., Parry S., Elkousy M., et al. A polymorphism in the promoter region of TNF and bacterial vaginosis: preliminary evidence of gene-environment interaction in the etiology of spontaneous preterm birth. Am J Obstet Gynecol 2004, 190(6):1504-1508. [discussion: 1503A].
88. Gomez L.M., Sammel M.D., Appleby D.H., et al. Evidence of a gene-environment interaction that predisposes to spontaneous preterm birth: a role for asymptomatic bacterial vaginosis and DNA variants in genes that control the inflammatory response. Am J Obstet Gynecol 2010, 202(4):386. e381-6.
89. Engel S.A., Erichsen H.C., Savitz D.A., et al. Risk of spontaneous preterm birth is associated with common proinflammatory cytokine polymorphisms. Epidemiology 2005, 16(4):469-477.
90. Carroll S.G., Nicolaides K.H. Fetal haematological response to intra-uterine infection in preterm prelabour amniorrhexis. Fetal Diagn Ther 1995, 10(5):279-285.
91. Alexander J.M., Gilstrap L.C., Cox S.M., et al. Clinical chorioamnionitis and the prognosis for very low birth weight infants. Obstet Gynecol 1998, 91(5 Pt 1):725-729.
92. Hitti J., Tarczy-Hornoch P., Murphy J., et al. Amniotic fluid infection, cytokines, and adverse outcome among infants at 34 weeks' gestation or less. Obstet Gynecol 2001, 98(6):1080-1088.
93. Wu Y.W., Colford J.M. Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis. JAMA 2000, 284(11):1417-1424.
94. Leviton A., Paneth N. White matter damage in preterm newborns-an epidemiologic perspective. Early Hum Dev 1990, 24(1):1-22.
95. Yoon B.H., Romero R., Park J.S., et al. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 2000, 182(3):675-681.
96. Johnson S., Hollis C., Kochhar P., et al. Psychiatric disorders in extremely preterm children: longitudinal finding at age 11 years in the EPICure study. J Am Acad Child Adolesc Psychiatry 2010, 49(5):453-463. e451.
97. Schieve L.A., Baio J., Rice C.E., et al. Risk for cognitive deficit in a population-based sample of U.S. children with autism spectrum disorders: variation by perinatal health factors. Disabil Health J 2010, 3(3):202-212.
98. Indredavik M.S. Extremely preterm children at increased risk of autism spectrum disorders. Evid Based Ment Health 2010, 13(3):92.
99. Johnson S., Hollis C., Kochhar P., et al. Autism spectrum disorders in extremely preterm children. J Pediatr 2010, 156(4):525-531. e522.
100. Gomez R., Romero R., Ghezzi F., et al. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998, 179(1):194-202.
101. Pacora P., Chaiworapongsa T., Maymon E., et al. Funisitis and chorionic vasculitis: the histological counterpart of the fetal inflammatory response syndrome. J Matern Fetal Neonatal Med 2002, 11(1):18-25.
102. Romero R., Gomez R., Ghezzi F., et al. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol 1998, 179(1):186-193.
103. Wenstrom K.D., Andrews W.W., Tamura T., et al. Elevated amniotic fluid interleukin-6 levels at genetic amniocentesis predict subsequent pregnancy loss. Am J Obstet Gynecol 1996, 175(4 Pt 1):830-833.
104. Arntzen K.J., Kjollesdal A.M., Halgunset J., et al. IL-1, IL-6, IL-8 and soluble TNF receptors in relation to chorioamnionitis and premature labor. J Perinat Med 1998, 26(1):17-26.
105. Steinborn A., Kuhnert M., Halberstadt E. Immunmodulating cytokines induce term and preterm parturition. J Perinat Med 1996, 24(4):381-390.
106. Maeda K., Matsuzaki N., Fuke S., et al. Value of the maternal interleukin 6 level for determination of histologic chorioamnionitis in preterm delivery. Gynecol Obstet Invest 1997, 43(4):225-231.
107. Tu F.F., Goldenberg R.L., Tamura T., et al. Prenatal plasma matrix metalloproteinase-9 levels to predict spontaneous preterm birth. Obstet Gynecol 1998, 92(3):446-449.
108. Wei S.Q., Fraser W., Luo Z.C. Inflammatory cytokines and spontaneous preterm birth in asymptomatic women: a systematic review. Obstet Gynecol 2010, 116(2 Pt 1):393-401.
109. Thomakos N., Daskalakis G., Papapanagiotou A., et al. Amniotic fluid interleukin-6 and tumor necrosis factor-alpha at mid-trimester genetic amniocentesis: relationship to intra-amniotic microbial invasion and preterm delivery. Eur J Obstet Gynecol Reprod Biol 2010, 148(2):147-151.
110. Daskalakis G., Thomakos N., Papapanagiotou A., et al. Amniotic fluid interleukin-18 at mid-trimester genetic amniocentesis: relationship to intraamniotic microbial invasion and preterm delivery. BJOG 2009, 116(13):1743-1748.
111. Kusanovic J.P., Romero R., Jodicke C., et al. Amniotic fluid soluble human leukocyte antigen-G in term and preterm parturition, and intra-amniotic infection/inflammation. J Matern Fetal Neonatal Med 2009, 22(12):1151-1166.
112. Soto E., Romero R., Richani K., et al. Evidence for complement activation in the amniotic fluid of women with spontaneous preterm labor and intra-amniotic infection. J Matern Fetal Neonatal Med 2009, 22(11):983-992.
113. Bastek J.A., Brown A.G., Anton L., et al. Biomarkers of inflammation and placental dysfunction are associated with subsequent preterm birth. J Matern Fetal Neonatal Med 2011, 24(4):600-605.
114. Lockwood C.J., Senyei A.E., Dische M.R., et al. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 1991, 325(10):669-674.
115. Feinberg R.F., Kliman H.J., Lockwood C.J. Is oncofetal fibronectin a trophoblast glue for human implantation?. Am J Pathol 1991, 138(3):537-543.
116. Lu G.C., Goldenberg R.L., Cliver S.P., et al. Vaginal fetal fibronectin levels and spontaneous preterm birth in symptomatic women. Obstet Gynecol 2001, 97(2):225-228.
117. Meis P.J., Klebanoff M., Thom E., et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003, 348(24):2379-2385.
118. Beck P., Adler P., Szlachter N., et al. Synergistic effect of human relaxin and progesterone on human myometrial contractions. Int J Gynaecol Obstet 1982, 20(2):141-144.
119. Astle S., Slater D.M., Thornton S. The involvement of progesterone in the onset of human labour. Eur J Obstet Gynecol Reprod Biol 2003, 108(2):177-181.
120. Buhimschi I.A., Buhimschi C.S., Weiner C.P. Protective effect of N-acetylcysteine against fetal death and preterm labor induced by maternal inflammation. Am J Obstet Gynecol 2003, 188(1):203-208.
121. Vrachnis N., Vitoratos N., Iliodromiti Z., et al. Intrauterine inflammation and preterm delivery. Ann N Y Acad Sci 2010, 1205:118-122.
122. Cowchock S. Prevention of fetal death in the antiphospholipid antibody syndrome. Lupus 1996, 5(5):467-472.
123. Kramer B.W., Moss T.J., Willet K.E., et al. Dose and time response after intraamniotic endotoxin in preterm lambs. Am J Respir Crit Care Med 2001, 164(6):982-988.
124. Newnham J.P., Moss T.J., Kramer B.W., et al. The fetal maturational and inflammatory responses to different routes of endotoxin infusion in sheep. Am J Obstet Gynecol 2002, 186(5):1062-1068.
125. Mitchell B.F., Taggart M.J. Are animal models relevant to key aspects of human parturition?. Am J Physiol Regul Integr Comp Physiol 2009, 297(3):R525-R545.
126. Gravett M.G., Adams K.M., Sadowsky D.W., et al. Immunomodulators plus antibiotics delay preterm delivery after experimental intraamniotic infection in a nonhuman primate model. Am J Obstet Gynecol 2007, 197(5):518. e511-8.
127. Hirsch E., Saotome I., Hirsh D. A model of intrauterine infection and preterm delivery in mice. Am J Obstet Gynecol 1995, 172(5):1598-1603.
128. Elovitz M.A., Wang Z., Chien E.K., et al. A new model for inflammation-induced preterm birth: the role of platelet-activating factor and Toll-like receptor-4. Am J Pathol 2003, 163(5):2103-2111.
129. Warburton D., Schwarz M., Tefft D., et al. The molecular basis of lung morphogenesis. Mech Dev 2000, 92(1):55-81.
130. Elovitz M.A., Mrinalini C. Can medroxyprogesterone acetate alter Toll-like receptor expression in a mouse model of intrauterine inflammation?. Am J Obstet Gynecol 2005, 193(3 Pt 2):1149-1155.
131. Elovitz M.A., Mrinalini C. The use of progestational agents for preterm birth: lessons from a mouse model. Am J Obstet Gynecol 2006, 195(4):1004-1010.
132. Schlafer D.H., Yuh B., Foley G.L., et al. Effect of Salmonella endotoxin administered to the pregnant sheep at 133-142 days gestation on fetal oxygenation, maternal and fetal adrenocorticotropic hormone and cortisol, and maternal plasma tumor necrosis factor alpha concentrations. Biol Reprod 1994, 50(6):1297-1302.
133. Grigsby P.L., Hirst J.J., Scheerlinck J.P., et al. Fetal responses to maternal and intra-amniotic lipopolysaccharide administration in sheep. Biol Reprod 2003, 68(5):1695-1702.
134. Dombroski R.A., Woodard D.S., Harper M.J., et al. A rabbit model for bacteria-induced preterm pregnancy loss. Am J Obstet Gynecol 1990, 163(6 Pt 1):1938-1943.
135. Heddleston L., McDuffie R.S., Gibbs R.S. A rabbit model for ascending infection in pregnancy: intervention with indomethacin and delayed ampicillin-sulbactam therapy. Am J Obstet Gynecol 1993, 169(3):708-712.
136. Davies J.K., Shikes R.H., Sze C.I., et al. Histologic inflammation in the maternal and fetal compartments in a rabbit model of acute intra-amniotic infection. Am J Obstet Gynecol 2000, 183(5):1088-1093.
137. Grigsby P.L., Novy M.J., Waldorf K.M., et al. Choriodecidual inflammation: a harbinger of the preterm labor syndrome. Reprod Sci 2010, 17(1):85-94.
138. Gravett M.G., Witkin S.S., Haluska G.J., et al. An experimental model for intraamniotic infection and preterm labor in rhesus monkeys. Am J Obstet Gynecol 1994, 171(6):1660-1667.
139. Novy M.J., Duffy L., Axthelm M.K., et al. Ureaplasma parvum or Mycoplasma hominis as sole pathogens cause chorioamnionitis, preterm delivery, and fetal pneumonia in rhesus macaques. Reprod Sci 2009, 16(1):56-70.
140. Sadowsky D.W., Haluska G.J., Gravett M.G., et al. Indomethacin blocks interleukin 1beta-induced myometrial contractions in pregnant rhesus monkeys. Am J Obstet Gynecol 2000, 183(1):173-180.
141. Sadowsky D.W., Adams K.M., Gravett M.G., et al. Preterm labor is induced by intraamniotic infusions of interleukin-1beta and tumor necrosis factor-alpha but not by interleukin-6 or interleukin-8 in a nonhuman primate model. Am J Obstet Gynecol 2006, 195(6):1578-1589.
142. Fidel P.L., Romero R., Wolf N., et al. Systemic and local cytokine profiles in endotoxin-induced preterm parturition in mice. Am J Obstet Gynecol 1994, 170(5 Pt 1):1467-1475.
143. Kaga N., Katsuki Y., Obata M., et al. Repeated administration of low-dose lipopolysaccharide induces preterm delivery in mice: a model for human preterm parturition and for assessment of the therapeutic ability of drugs against preterm delivery. Am J Obstet Gynecol 1996, 174(2):754-759.
144. Hirsch E., Muhle R.A., Mussalli G.M., et al. Bacterially induced preterm labor in the mouse does not require maternal interleukin-1 signaling. Am J Obstet Gynecol 2002, 186(3):523-530.
145. Wang H., Hirsch E. Bacterially-induced preterm labor and regulation of prostaglandin-metabolizing enzyme expression in mice: the role of toll-like receptor 4. Biol Reprod 2003, 69(6):1957-1963.
146. Liu H., Redline R.W., Han Y.W. Fusobacterium nucleatum induces fetal death in mice via stimulation of TLR4-mediated placental inflammatory response. J Immunol 2007, 179(4):2501-2508.
147. Alexopoulou L., Holt A.C., Medzhitov R., et al. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001, 413(6857):732-738.
148. Kawai T., Adachi O., Ogawa T., et al. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 1999, 11(1):115-122.
149. Filipovich Y., Lu S.J., Akira S., et al. The adaptor protein MyD88 is essential for E coli-induced preterm delivery in mice. Am J Obstet Gynecol 2009, 200(1):93. e91-8.
150. Word R.A., Li X.H., Hnat M., et al. Dynamics of cervical remodeling during pregnancy and parturition: mechanisms and current concepts. Semin Reprod Med 2007, 25(1):69-79.
151. Gonzalez J.M., Xu H., Chai J., et al. Preterm and term cervical ripening in CD1 Mice (Mus musculus): similar or divergent molecular mechanisms?. Biol Reprod 2009, 81(6):1226-1232.
152. Straach K.J., Shelton J.M., Richardson J.A., et al. Regulation of hyaluronan expression during cervical ripening. Glycobiology 2005, 15(1):55-65.
153. Liggins G.C. Ripening of the cervix. Semin Perinatol 1978, 2(3):261-271.
154. Kelly R.W. Inflammatory mediators and cervical ripening. J Reprod Immunol 2002, 57(1/2):217-224.
155. Hassan S.S., Romero R., Haddad R., et al. The transcriptome of the uterine cervix before and after spontaneous term parturition. Am J Obstet Gynecol 2006, 195(3):778-786.
156. Timmons B.C., Fairhurst A.M., Mahendroo M.S. Temporal changes in myeloid cells in the cervix during pregnancy and parturition. J Immunol 2009, 182(5):2700-2707.
157. Uchiyama T., Sakuta T., Kanayama T. Regulation of hyaluronan synthases in mouse uterine cervix. Biochem Biophys Res Commun 2005, 327(3):927-932.
158. Elovitz M., Wang Z. Medroxyprogesterone acetate, but not progesterone, protects against inflammation-induced parturition and intrauterine fetal demise. Am J Obstet Gynecol 2004, 190(3):693-701.
159. Timmons B., Akins M., Mahendroo M. Cervical remodeling during pregnancy and parturition. Trends Endocrinol Metab 2010, 21(6):353-361.
160. Timmons B.C., Mahendroo M. Processes regulating cervical ripening differ from cervical dilation and postpartum repair: insights from gene expression studies. Reprod Sci 2007, 14(Suppl 8):53-62.
161. Xu H., Gonzalez J.M., Ofori E., et al. Preventing cervical ripening: the primary mechanism by which progestational agents prevent preterm birth?. Am J Obstet Gynecol 2008, 198(3):314. e311-8.
162. Hirsch E., Wang H. The molecular pathophysiology of bacterially induced preterm labor: insights from the murine model. J Soc Gynecol Investig 2005, 12(3):145-155.
163. Bry K., Hallman M. Transforming growth factor-beta opposes the stimulatory effects of interleukin-1 and tumor necrosis factor on amnion cell prostaglandin E2 production: implication for preterm labor. Am J Obstet Gynecol 1992, 167(1):222-226.
164. Grether J.K., Nelson K.B. Maternal infection and cerebral palsy in infants of normal birth weight. JAMA 1997, 278(3):207-211.
165. Dammann O., Leviton A. Infection remote from the brain, neonatal white matter damage, and cerebral palsy in the preterm infant. Semin Pediatr Neurol 1998, 5(3):190-201.
166. Limperopoulos C., Bassan H., Sullivan N.R., et al. Positive screening for autism in ex-preterm infants: prevalence and risk factors. Pediatrics 2008, 121(4):758-765.
167. Lindstrom K., Lindblad F., Hjern A. Psychiatric morbidity in adolescents and young adults born preterm: a Swedish national cohort study. Pediatrics 2009, 123(1):e47-e53.
168. Elovitz M.A., Mrinalini C., Sammel M.D. Elucidating the early signal transduction pathways leading to fetal brain injury in preterm birth. Pediatr Res 2006, 59(1):50-55.
169. Burd I., Chai J., Gonzalez J., et al. Beyond white matter damage: fetal neuronal injury in a mouse model of preterm birth. Am J Obstet Gynecol 2009, 201(3):279. e271-8.
170. Bell M.J., Hallenbeck J.M. Effects of intrauterine inflammation on developing rat brain. J Neurosci Res 2002, 70(4):570-579.
171. Burd I., Bentz A.I., Chai J., et al. Inflammation-induced preterm birth alters neuronal morphology in the mouse fetal brain. J Neurosci Res 2010, 88(9):1872-1881.
172. Terrone D.A., Rinehart B.K., Granger J.P., et al. Interleukin-10 administration and bacterial endotoxin-induced preterm birth in a rat model. Obstet Gynecol 2001, 98(3):476-480.
173. Scott D.L., Wolfe F., Huizinga T.W. Rheumatoid arthritis. Lancet 2010, 376(9746):1094-1108.
174. Szekeres-Bartho J., Barakonyi A., Par G., et al. Progesterone as an immunomodulatory molecule. Int Immunopharmacol 2001, 1(6):1037-1048.
175. Bamberger C.M., Else T., Bamberger A.M., et al. Dissociative glucocorticoid activity of medroxyprogesterone acetate in normal human lymphocytes. J Clin Endocrinol Metab 1999, 84(11):4055-4061.
176. Simoncini T., Mannella P., Fornari L., et al. Differential signal transduction of progesterone and medroxyprogesterone acetate in human endothelial cells. Endocrinology 2004, 145(12):5745-5756.
177. Adams Waldorf K.M., Persing D., Novy M.J., et al. Pretreatment with toll-like receptor 4 antagonist inhibits lipopolysaccharide-induced preterm uterine contractility, cytokines, and prostaglandins in rhesus monkeys. Reprod Sci 2008, 15(2):121-127.
178. Lappas M., Permezel M., Georgiou H.M., et al. Regulation of phospholipase isozymes by nuclear factor-kappaB in human gestational tissues in vitro. J Clin Endocrinol Metab 2004, 89(5):2365-2372.
179. Barnes P.J., Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997, 336(15):1066-1071.
180. Schenk H., Klein M., Erdbrugger W., et al. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1. Proc Natl Acad Sci U S A 1994, 91(5):1672-1676.
181. Kim H., Seo J.Y., Roh K.H., et al. Suppression of NF-kappaB activation and cytokine production by N-acetylcysteine in pancreatic acinar cells. Free Radic Biol Med 2000, 29(7):674-683.
182. Verhasselt V., Vanden Berghe W., Vanderheyde N., et al. N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-kappaB inhibition. J Immunol 1999, 162(5):2569-2574.
183. Pahan K., Sheikh F.G., Namboodiri A.M., et al. N-acetyl cysteine inhibits induction of no production by endotoxin or cytokine stimulated rat peritoneal macrophages, C6 glial cells and astrocytes. Free Radic Biol Med 1998, 24(1):39-48.
184. Paintlia M.K., Paintlia A.S., Singh A.K., et al. Attenuation of lipopolysaccharide-induced inflammatory response and phospholipids metabolism at the feto-maternal interface by N-acetyl cysteine. Pediatr Res 2008, 64(4):334-339.
185. Xu D.X., Chen Y.H., Wang H., et al. Effect of N-acetylcysteine on lipopolysaccharide-induced intra-uterine fetal death and intra-uterine growth retardation in mice. Toxicol Sci 2005, 88(2):525-533.
186. Probyn M.E., Cock M.L., Duncan J.R., et al. The anti-inflammatory agent N-acetyl cysteine exacerbates endotoxin-induced hypoxemia and hypotension and induces polycythemia in the ovine fetus. Neonatology 2010, 98(2):118-127.